Dispositifs de délivrance de principes actifs pour des applications ophtalmologiques [Drug delivery systems for intraocular applications].


Autoria(s): Bourges J.L.; Touchard E.; Kowalczuk L.; Berdugo M.; Thomas-Doyle A.; Bochot A.; Gomez A.; Azan F.; Gurny R.; Behar-Cohen F.
Data(s)

2007

Resumo

Numerous drug delivery systems (DDSs) can be used as intraocular tools to provide a sustained and calibrated release for a specific drug. Great progress has been made on the design, biocompatibility, bioavailability, and efficacy of DDSs. Although several of them are undergoing clinical trials, a few are already on the market and could be of a routine use in clinical practice. Moreover, miniaturization of the implants makes them less and less traumatic for the eye tissues and some DDSs are now able to target certain cells or tissues specifically. An overview of ocular implants with therapeutic application potentials is provided.

Identificador

https://serval.unil.ch/?id=serval:BIB_D0274BCEA57C

isbn:1773-0597 (Electronic)

pmid:18268450

isiid:000252616900015

doi:10.1016/S0181-5512(07)79290-2

Idioma(s)

fr

Fonte

Journal Français D'ophtalmologie, vol. 30, no. 10, pp. 1070-1088

Palavras-Chave #Animals; Delayed-Action Preparations; Drug Delivery Systems/instrumentation; Drug Implants; Equipment Design; Eye/drug effects; Eye Diseases/drug therapy; Humans; Liposomes; Miniaturization; Nanoparticles; Particle Size; Polymers; Prostheses and Implants; Vitreous Body/drug effects; Vitreous Body/pathology
Tipo

info:eu-repo/semantics/review

article